{"id":"W4405044303","doi":"10.1182/blood-2024-209438","title":"Addition of Inotuzumab to a Pediatric Inspired Chemotherapy Regimen in Young Adult Patients with B-Cell Acute Lymphoblastic Leukemia: Findings from the Alliance A041501 Phase 3 Randomized Trial","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Daiichi Sankyo Europe; Servier; Astellas Pharma; CTI Biopharma; Incyte; MacroGenics; Syndax Pharmaceuticals; BeiGene; Jazz Pharmaceuticals; Alexion Pharmaceuticals; Seagen; Gilead Sciences; GlaxoSmithKline; Amgen","keywords":"Medicine; Regimen; Chemotherapy regimen; Acute lymphocytic leukemia; Chemotherapy; Lymphoblastic Leukemia; Oncology; Pediatrics; Randomized controlled trial; Internal medicine; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001722503,0.0006151434,0.001024828,0.000219655,0.0002145062,0.0008733956,0.0004800871,0.0007241513,0.002865534],"category_scores_gemma":[0.001463908,0.000287243,0.00150275,0.0003638397,0.0003974798,0.0005526209,0.0002665859,0.001779835,0.0004240266],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009449229,"about_ca_system_score_gemma":0.001231141,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001184446,"about_ca_topic_score_gemma":0.003376197,"domain_scores_codex":[0.999511,0.0003121088,0.00003599855,0.00005335688,0.00003762972,0.00004983768],"domain_scores_gemma":[0.9992362,0.000173081,0.0002646388,0.00004772872,0.0000477218,0.000230473],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9158754,0.005420919,0.009846036,0.001031784,0.003253057,0.0001209086,0.0001384652,0.0007091276,0.003468513,0.0003283129,0.003719248,0.05608818],"study_design_scores_gemma":[0.832042,0.1275226,0.02703097,0.0003586985,0.003943815,0.0003311145,0.0001080319,0.000903536,0.0008411873,0.0004992423,0.00638755,0.00003116912],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9800789,0.0118518,0.0003818753,0.001098986,0.000283751,0.001816246,0.001606013,0.00007203307,0.002810381],"genre_scores_gemma":[0.9831914,0.006883095,0.00147626,0.001954748,0.0002698391,0.002808445,0.002083997,0.00001744322,0.00131484],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002865534,"threshold_uncertainty_score":0.009586155,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006396132666171618,"score_gpt":0.2523164362831921,"score_spread":0.2459203036170205,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}